• 1
    Klippel JH, Crofford LJ, Stone JH, Weyand CM.Primer on the rheumatic diseases. 12th ed.Atlanta:Arthritis Foundation;2001.
  • 2
    Scott DL, Smith C, Kingsley G.What are the consequences of early rheumatoid arthritis for the individual?Best Pract Res Clin Rheumatol2005;19:11736.
  • 3
    American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines.Guidelines for the management of rheumatoid arthritis: 2002 update.Arthritis Rheum2002;46:32846.
  • 4
    Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al.2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.Arthritis Care Res (Hoboken)2012;64:62539.
  • 5
    Lee DM, Weinblatt M.Rheumatoid arthritis.Lancet2001;358:90311.
  • 6
    Bogardus ST Jr, Holmboe E, Jekel JF.Perils, pitfalls, and possibilities in talking about medical risk.JAMA1999;281:103741.
  • 7
    Fraenkel L, Bogardus S, Concato J, Felson D.Risk communication in rheumatoid arthritis.J Rheumatol2003;30:4438.
  • 8
    Fraenkel L, Peters E.Patients' reaction to the disclosure of rare dreaded adverse events.Patient Educ Couns2011;84:e14.
  • 9
    Reyna VF.How people make decisions that involve risk: a dual-process approach.Curr Dir Psychol Sci2004;13:606.
    Direct Link:
  • 10
    Reyna VF, Brainerd CJ.Fuzzy-trace theory: an interim synthesis.Learn Individ Differ1995;7:175.
  • 11
    Reyna VF, Lloyd FJ.Physician decision making and cardiac risk: effects of knowledge, risk perception, risk tolerance, and fuzzy processing.J Exp Psychol Appl2006;12:17995.
  • 12
    Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F.The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis.Arthritis Rheum1992;35:498502.
  • 13
    Haugeberg G, Orstavik RE, Kvien TK.Effects of rheumatoid arthritis on bone.Curr Opin Rheumatol2003;15:46975.
  • 14
    SAS Institute.SAS/STAT 9.1.Cary (NC):SAS Institute;2001.
  • 15
    Tibaldi G, Clatworthy J, Torchio E, Argentero P, Munizza C, Horne R.The utility of the Necessity–Concerns Framework in explaining treatment non-adherence in four chronic illness groups in Italy.Chronic Illn2009;5:12933.
  • 16
    Jonsdottir H, Friis S, Horne R, Pettersen KI, Reikvam A, Andreassen OA.Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders.Acta Psychiatr Scand2009;119:7884.
  • 17
    Menckeberg TT, Bouvy ML, Bracke M, Kaptein AA, Leufkens HG, Raaijmakers JA, et al.Beliefs about medicines predict refill adherence to inhaled corticosteroids.J Psychosom Res2008;64:4754.
  • 18
    Brask-Lindemann D, Cadarette SM, Eskildsen P, Abrahamsen B.Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results.Osteoporos Int2011;22:1493501.
  • 19
    Elstad E, Carpenter DM, Devellis RF, Blalock SJ.Patient decision making in the face of conflicting medication information.Int J Qual Stud Health Well-being2012;7:111.
  • 20
    Carpenter DM, DeVellis RF, Fisher EB, DeVellis BM, Hogan SL, Jordan JM.The effect of conflicting medication information and physician support on medication adherence for chronically ill patients.Patient Educ Couns2010;81:16976.
  • 21
    Tait AR, Zikmund-Fisher BJ, Fagerlin A, Voepel-Lewis T.The effect of various risk/benefit trade-offs on parents' understanding of a pediatric research study.Pediatrics2010;125:e147582.
  • 22
    Hawley ST, Zikmund-Fisher B, Ubel P, Jancovic A, Lucas T, Fagerlin A.The impact of the format of graphical presentation on health-related knowledge and treatment choices.Patient Educ Couns2008;73:44855.
  • 23
    Fraenkel L, Peters E, Charpentier P, Olsen B, Errante L, Schoen RT, et al.Decision tool to improve the quality of care in rheumatoid arthritis.Arthritis Care Res (Hoboken)2012;64:97785.